Biogen, Inc.
(NASDAQ : BIIB)

( )
BIIB PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -0.10%159.870.0%$1295.48m
AMGNAmgen, Inc. 2.21%255.131.3%$694.68m
SNSSSunesis Pharmaceuticals, Inc. 1.90%8.030.7%$561.33m
NVAXNovavax, Inc. 0.37%202.0980.0%$556.50m
ILMNIllumina, Inc. 0.98%401.963.5%$517.94m
GILDGilead Sciences, Inc. 0.72%65.771.0%$463.29m
REGNRegeneron Pharmaceuticals, Inc. 2.80%494.642.7%$449.68m
VRTXVertex Pharmaceuticals, Inc. 1.83%221.101.9%$383.88m
ALXNAlexion Pharmaceuticals, Inc. 1.45%157.542.0%$298.86m
BNTXBioNTech SE 6.12%140.720.0%$266.37m
BIIBBiogen, Inc. 1.75%270.441.7%$264.45m
EXASEXACT Sciences Corp. 2.66%130.5218.4%$192.20m
NBIXNeurocrine Biosciences, Inc. -0.05%95.004.9%$177.73m
CRSPCRISPR Therapeutics AG 0.60%123.850.6%$174.50m
SGENSeagen Inc. 3.77%149.645.8%$153.69m

Company Profile

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.